Communicating 5-Year Risk of Alzheimer’s Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results | Zendy

Jessica Mozersky | Zendy; Sarah M. Hartz | Zendy; Erin Linnenbringer | Zendy; Lillie Levin | Zendy; Marissa Streitz | Zendy; Kristin Stock | Zendy; Krista L. Moulder | Zendy; John C. Morris | Zendy

Open Access

Communicating 5-Year Risk of Alzheimer’s Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results

Author(s) -

Jessica Mozersky,

Sarah M. Hartz,

Erin Linnenbringer,

Lillie Levin,

Marissa Streitz,

Kristin Stock,

Krista L. Moulder,

John C. Morris

Publication year - 2020

Publication title -

journal of alzheimer s disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.677

H-Index - 139

eISSN - 1875-8908

pISSN - 1387-2877

DOI - 10.3233/jad-200993

Subject(s) - dementia , psychosocial , clarity , disease , psychology , curiosity , gerontology , medicine , clinical psychology , psychiatry , pathology , neuroscience , biochemistry , chemistry

Cognitively normal (CN) older adults participating in Alzheimer's disease (AD) research increasingly ask for their research results-including genetic and neuroimaging findings-to understand their risk of developing AD dementia. AD research results are typically not returned for multiple reasons, including possible psychosocial harms of knowing one is at risk of a highly feared and untreatable disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research